• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定肠道微生物群(SIM)饮食对代谢性疾病的治疗潜力

The Therapeutic Potential of the Specific Intestinal Microbiome (SIM) Diet on Metabolic Diseases.

作者信息

Chu Natural H S, Chow Elaine, Chan Juliana C N

机构信息

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.

Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.

出版信息

Biology (Basel). 2024 Jul 4;13(7):498. doi: 10.3390/biology13070498.

DOI:10.3390/biology13070498
PMID:39056692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273990/
Abstract

Exploring the intricate crosstalk between dietary prebiotics and the specific intestinal microbiome (SIM) is intriguing in explaining the mechanisms of current successful dietary interventions, including the Mediterranean diet and high-fiber diet. This knowledge forms a robust basis for developing a new natural food therapy. The SIM diet can be measured and evaluated to establish a reliable basis for the management of metabolic diseases, such as diabetes, metabolic (dysfunction)-associated fatty liver disease (MAFLD), obesity, and metabolic cardiovascular disease. This review aims to delve into the existing body of research to shed light on the promising developments of possible dietary prebiotics in this field and explore the implications for clinical practice. The exciting part is the crosstalk of diet, microbiota, and gut-organ interactions facilitated by producing short-chain fatty acids, bile acids, and subsequent metabolite production. These metabolic-related microorganisms include , , and The SIM diet, rather than supplementation, holds the promise of significant health consequences via the prolonged reaction with the gut microbiome. Most importantly, the literature consistently reports no adverse effects, providing a strong foundation for the safety of this dietary therapy.

摘要

探索膳食益生元与特定肠道微生物群(SIM)之间复杂的相互作用,对于解释当前成功的膳食干预机制(包括地中海饮食和高纤维饮食)具有重要意义。这一知识为开发新的天然食物疗法奠定了坚实基础。SIM饮食可以进行测量和评估,从而为糖尿病、代谢(功能障碍)相关脂肪性肝病(MAFLD)、肥胖症和代谢性心血管疾病等代谢性疾病的管理建立可靠依据。本综述旨在深入研究现有研究成果,以揭示该领域中膳食益生元可能的有前景的发展,并探讨其对临床实践的影响。令人兴奋的是,通过产生短链脂肪酸、胆汁酸以及随后的代谢产物生成,饮食、微生物群和肠道 - 器官相互作用之间存在相互影响。这些与代谢相关的微生物包括……(原文此处未完整列出微生物名称)。SIM饮食而非补充剂,通过与肠道微生物群的长期相互作用,有望对健康产生重大影响。最重要的是,文献一致报道无不良影响,为这种饮食疗法的安全性提供了有力依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493a/11273990/cf5c5e462385/biology-13-00498-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493a/11273990/6f71ae9933ba/biology-13-00498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493a/11273990/cf5c5e462385/biology-13-00498-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493a/11273990/6f71ae9933ba/biology-13-00498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493a/11273990/cf5c5e462385/biology-13-00498-g002.jpg

相似文献

1
The Therapeutic Potential of the Specific Intestinal Microbiome (SIM) Diet on Metabolic Diseases.特定肠道微生物群(SIM)饮食对代谢性疾病的治疗潜力
Biology (Basel). 2024 Jul 4;13(7):498. doi: 10.3390/biology13070498.
2
'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.“通往男人心的路是通过他的肠道微生物群”——用于管理心血管风险的饮食益生菌和益生元。
Proc Nutr Soc. 2014 May;73(2):172-85. doi: 10.1017/S0029665113003911. Epub 2014 Feb 4.
3
The role of diet and intestinal microbiota in the development of metabolic syndrome.饮食和肠道微生物群在代谢综合征发展中的作用。
J Nutr Biochem. 2019 Aug;70:1-27. doi: 10.1016/j.jnutbio.2019.03.017. Epub 2019 Apr 8.
4
Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.饮食诱导肥胖中,胃旁路手术微生物群的功能变化通过肠道 FXR-TGR5 串扰重新激活产热脂肪组织和全身葡萄糖控制。
Microbiome. 2022 Jun 24;10(1):96. doi: 10.1186/s40168-022-01264-5.
5
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD).多糖:代谢相关脂肪性肝病(MAFLD)的潜在益生元。
Nutrients. 2023 Aug 25;15(17):3722. doi: 10.3390/nu15173722.
6
Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition.肠道微生物群产生的短链脂肪酸根据益生菌选择和细菌群落组成在肥胖儿童中存在差异。
mBio. 2020 Aug 11;11(4):e00914-20. doi: 10.1128/mBio.00914-20.
7
Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease.揭示肠道-心脏轴:探索肠道微生物群在心血管健康与疾病中的作用。
Ann Med Surg (Lond). 2024 Jan 18;86(5):2752-2758. doi: 10.1097/MS9.0000000000001744. eCollection 2024 May.
8
Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.短链脂肪酸作为饮食与心脏代谢风险之间的联系:叙述性综述。
Lipids Health Dis. 2023 Mar 14;22(1):40. doi: 10.1186/s12944-023-01803-5.
9
Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.BRIDGE-CRC 试验的设计:一项为期 6 个月、平行组、针对胆汁酸-肠道微生物组轴的地中海饮食和减肥随机对照生活方式干预,旨在降低肥胖的非裔美国/黑人成年人的结直肠癌风险。
Trials. 2023 Feb 15;24(1):113. doi: 10.1186/s13063-023-07115-4.
10
Gut microbiome-Mediterranean diet interactions in improving host health.肠道微生物群与地中海饮食在改善宿主健康方面的相互作用。
F1000Res. 2019 May 21;8:699. doi: 10.12688/f1000research.18992.1. eCollection 2019.

引用本文的文献

1
Combining a diet rich in fermentable carbohydrates with metformin improves glycaemic control and reshapes the gut microbiota in people with prediabetes.将富含可发酵碳水化合物的饮食与二甲双胍相结合,可改善糖尿病前期患者的血糖控制并重塑其肠道微生物群。
Nat Metab. 2025 Jul 31. doi: 10.1038/s42255-025-01336-4.
2
Structural analysis and prebiotic properties of the polysaccharides produced by YT013.YT013产生的多糖的结构分析及益生元特性
Food Chem X. 2025 Jun 2;28:102600. doi: 10.1016/j.fochx.2025.102600. eCollection 2025 May.
3
Dietary Manipulation on Gut Microbiome in Patients with Diabetes and Colorectal cancer.

本文引用的文献

1
Higher Short-Chain Fermentable Carbohydrates Are Associated with Lower Body Fat and Higher Insulin Sensitivity in People with Prediabetes.高短链可发酵碳水化合物与前驱糖尿病患者体脂降低和胰岛素敏感性增加有关。
Nutrients. 2023 Dec 11;15(24):5070. doi: 10.3390/nu15245070.
2
A cross-sectional study of nutritional status in healthy, young, physically-active German omnivores, vegetarians and vegans reveals adequate vitamin B status in supplemented vegans.一项针对健康、年轻、活跃的德国杂食者、素食者和严格素食者营养状况的横断面研究表明,补充剂素食者的维生素 B 状况充足。
Ann Med. 2023;55(2):2269969. doi: 10.1080/07853890.2023.2269969. Epub 2023 Oct 18.
3
糖尿病和结直肠癌患者肠道微生物群的饮食调控
Curr Nutr Rep. 2025 Jun 3;14(1):75. doi: 10.1007/s13668-025-00667-8.
4
Carbohydrate Quality Is Independently Associated with Cardiometabolic Risk in Chinese Individuals with Impaired Glucose Tolerance.在中国糖耐量受损个体中,碳水化合物质量与心血管代谢风险独立相关。
Nutrients. 2025 Mar 24;17(7):1123. doi: 10.3390/nu17071123.
5
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review.理解肠道微生物群的复杂功能:其对肥胖及其他疾病发病机制的影响:综述
Diabetol Metab Syndr. 2024 Dec 23;16(1):308. doi: 10.1186/s13098-024-01561-z.
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.
抗性淀粉通过改变肠道微生物组降低非酒精性脂肪性肝病患者的肝内甘油三酯。
Cell Metab. 2023 Sep 5;35(9):1530-1547.e8. doi: 10.1016/j.cmet.2023.08.002.
4
Gut microbial carbohydrate metabolism contributes to insulin resistance.肠道微生物的碳水化合物代谢有助于胰岛素抵抗。
Nature. 2023 Sep;621(7978):389-395. doi: 10.1038/s41586-023-06466-x. Epub 2023 Aug 30.
5
New metrics of dietary carbohydrate quality.新的膳食碳水化合物质量指标。
Curr Opin Clin Nutr Metab Care. 2023 Jul 1;26(4):358-363. doi: 10.1097/MCO.0000000000000933. Epub 2023 May 19.
6
Supplementation with inulin-type fructans affects gut microbiota and attenuates some of the cardiometabolic benefits of a plant-based diet in individuals with overweight or obesity.补充菊粉型果聚糖会影响肠道微生物群,并削弱植物性饮食对超重或肥胖个体的一些心血管代谢益处。
Front Nutr. 2023 Apr 25;10:1108088. doi: 10.3389/fnut.2023.1108088. eCollection 2023.
7
Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis.车前子是一种天然的非发酵胶凝纤维,对减肥有效:全面综述和荟萃分析。
J Am Assoc Nurse Pract. 2023 Aug 1;35(8):468-476. doi: 10.1097/JXX.0000000000000882.
8
Dietary supplementation with resistant starch contributes to intestinal health.膳食纤维补充剂有助于肠道健康。
Curr Opin Clin Nutr Metab Care. 2023 Jul 1;26(4):334-340. doi: 10.1097/MCO.0000000000000939. Epub 2023 Apr 14.
9
An analysis of how lactose modifies the gut microbiota structure and function of adults in a donor-independent manner.一项关于乳糖如何以不依赖供体的方式改变成年人肠道微生物群结构和功能的分析。
Front Nutr. 2023 Jan 26;9:1040744. doi: 10.3389/fnut.2022.1040744. eCollection 2022.
10
Pectin in Metabolic Liver Disease.代谢性肝病中的果胶。
Nutrients. 2022 Dec 29;15(1):157. doi: 10.3390/nu15010157.